— Know what they know.
Not Investment Advice

EVFM OTC

Evofem Biosciences, Inc.
1W: -3.9% 1M: -7.5% 3M: -22.1% YTD: -22.1% 1Y: -44.8% 3Y: -94.7% 5Y: -100.0%
$0.01
+0.00 (+10.81%)
 
Weekly Expected Move ±7.8%
$0 $0 $0 $0 $0
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $1.1M mcap · 133M float · 0.172% daily turnover · Short 15% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.1M
52W Range0.0008-0.02
Volume1,049
Avg Volume227,698
Beta-1.29
Dividend—
Analyst Ratings
7 Buy 1 Hold 1 Sell
Consensus Buy
Company Info
CEOSaundra Pelletier
Employees29
SectorHealthcare
IndustryBiotechnology
IPO Date2014-11-20
Websiteevofem.com
7770 Regents Rd
San Diego, CA 92122-1967
US
858 550 1900
About Evofem Biosciences, Inc.

Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.

Recent Insider Trades

NameTypeSharesPriceDate
Zhang Yan S-Sale 104 $0.04 2024-01-12
Kamdar Kim P. S-Sale 10 $0.62 2023-12-21
Zhang Yan 0 — 2023-04-13
File Justin J. 0 — 2022-12-31
PELLETIER SAUNDRA L D-Return 50,000 — 2022-12-31

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms